CLINICAL TRIALS PROFILE FOR FENFLURAMINE HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for Fenfluramine Hydrochloride
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00000313 ↗ | Predictive Values of Serotonergic Alterations for Outcome - 2 | Terminated | VA Office of Research and Development | Phase 1 | 1969-12-31 | The purpose of this study is to evaluate the predictive value of serotonergic alterations for outcome. |
NCT00000313 ↗ | Predictive Values of Serotonergic Alterations for Outcome - 2 | Terminated | National Institute on Drug Abuse (NIDA) | Phase 1 | 1969-12-31 | The purpose of this study is to evaluate the predictive value of serotonergic alterations for outcome. |
NCT00000314 ↗ | M-CPP and Fenfluramine in Cocaine Addicts - 3 | Completed | VA Office of Research and Development | Phase 2 | 1994-09-01 | The purpose of this study is to evaluate predictive value of M-CPP and fenfluramine challenges for outcome. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Fenfluramine Hydrochloride
Condition Name
Clinical Trial Locations for Fenfluramine Hydrochloride
Trials by Country
Clinical Trial Progress for Fenfluramine Hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for Fenfluramine Hydrochloride
Sponsor Name